Dr. Robert J. Kuhn, MD

Dr. Kuhn practices at Cardiology Consultants of Philadelphia in Philadelphia, Pennsylvania.

Dr. Kuhn's NPI, 1205064482, was assigned on June 26, 2009. Dr. Kuhn graduated from State University of New York Downstate Medical Center in 2009. Dr. Kuhn holds Pennsylvania license MD457422.

Dr. Kuhn's primary practice is Cardiology Consultants of Philadelphia, at 207-9 N Broad St, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 463-5333.

Dr. Kuhn's primary practice is Cardiology Consultants of Philadelphia in Philadelphia, Pennsylvania. Dr. Kuhn is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Cardiology Consultants of Philadelphia. Dmand AI also links Dr. Kuhn to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kuhn practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kuhn's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kuhn is licensed in Pennsylvania.

CMS data shows 5,399 Medicare services from Dr. Kuhn across 22 procedure codes in 2024, for 1,468 Medicare patients. Medicare paid $574,403 for them.

CMS counts 1,468 Medicare patients who saw Dr. Kuhn in 2024. The largest group is 75 to 84, with 653 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kuhn's median patient age at 75, with 45% women.

In 2024, Dr. Kuhn wrote 6,437 Medicare Part D claims for 713 patients. 88% of them were for generic drugs. CMS names the drug for 6,167 of them, across 50 drugs with 11 or more claims each, at $902,216 in total drug cost. In 2023, CMS named 5,951 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kuhn for performance year 2024, reported as part of a group. Dr. Kuhn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kuhn as offering telehealth.

Dmand AI links 31 papers to Dr. Kuhn, published from 2010 to 2023. 2021 was the busiest year, with 4. The most frequent topics are Cystic Fibrosis, Anti-Bacterial Agents and Tobramycin. Dr. Kuhn has published most often in J Pediatr Pharmacol Ther. Dr. Kuhn's most frequent co-authors are Don Hayes, MD, Michael I. Anstead, MD and Jamshed Firoze Kanga, MD.

CMS Open Payments shows 29 general payments to Dr. Kuhn from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Boston Scientific Corporation paid the most, $671.

Dr. Kuhn graduated from State University of New York Downstate Medical Center in 2009.